Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

1.1K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.1K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.2K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

515
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
515
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

940
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
940
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

578
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
578
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

3.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

B cell-derived type I interferon sustains T cell functionality upon strong TCR stimulation during chronic infection.

Immunity·2026
Same author

Letter on 'Altered Pathogen Spectrum of Spontaneous Bacterial Peritonitis in Patients Treated With Proton Pump Inhibitors'. Authors' Reply.

Alimentary pharmacology & therapeutics·2026
Same author

Clinical impact of molecular tumor board inclusion on treatment outcomes in neuroendocrine neoplasms.

Neuroendocrinology·2026
Same author

Robust HLA-B-restricted CD8+ T-cell responses in chronic HBV infection.

JHEP reports : innovation in hepatology·2026
Same author

Determinants of long-term survival from atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Comparative performance of ReMELD-Na, MELD 3.0 and established scores after TIPS for refractory ascites: A multicenter study.

JHEP reports : innovation in hepatology·2026

相关实验视频

Updated: Feb 11, 2026

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
07:41

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

Published on: March 17, 2022

3.4K

[急性至慢性肝功能衰竭]

Klara-Luisa Budau, Robert Thimme, Lukas Sturm

    Deutsche medizinische Wochenschrift (1946)
    |February 9, 2026
    PubMed
    概括
    此摘要是机器生成的。

    急性至慢性肝衰竭 (ACLF) 是一种严重的肝硬化并发症,死亡率高. 早期干预,器官支持和肝移植是改善ACLF患者生存的关键.

    更多相关视频

    Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
    16:19

    Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

    Published on: September 13, 2014

    13.2K
    Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
    09:44

    Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

    Published on: November 27, 2019

    11.1K

    相关实验视频

    Last Updated: Feb 11, 2026

    Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
    07:41

    Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

    Published on: March 17, 2022

    3.4K
    Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
    16:19

    Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

    Published on: September 13, 2014

    13.2K
    Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
    09:44

    Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

    Published on: November 27, 2019

    11.1K

    科学领域:

    • 肝病学 肝病学是一种肝病学.
    • 关键护理医学 关键护理医学
    • 内部医学 内部医学

    背景情况:

    • 急性至慢性肝衰竭 (ACLF) 是不补偿性肝硬化患者的一种危及生命的综合征.
    • ACLF涉及一个或多个器官系统的急性衰竭,导致高短期死亡率,尽管临床进展.

    研究的目的:

    • 提供ACLF分类,诊断和治疗的更新,基于指南的概述.
    • 综合最新的文献和共识定义来管理ACLF.

    主要方法:

    • 对ACLF的当前文献和共识定义的审查.
    • 应用EASL-CLIF联盟标准来对ACLF进行分级.
    • 使用预后得分 (CLIF-C OF,CLIF-C ACLF,CLIF-C AD) 来进行风险分层.

    主要成果:

    • ACLF是由肝硬化与肝脏和/或其他器官衰竭 (脏,心血管,肺部,中枢神经系统,凝血) 的急性脱补偿定义的.
    • 根据EASL-CLIF联盟的标准,ACLF被分为三个等级,较高的等级与死亡率的增加有关.
    • 系统性炎症,通常由感染或胃肠道出血引发,是关键的病理生理特征.

    结论:

    • ACLF仍然是肝硬化的严重并发症,短期死亡率高.
    • 基于指导方针的早期干预,多学科管理和准确的风险分层改善了结果.
    • 肝移植是不可逆转的ACLF的唯一治疗方案;及时评估至关重要.